Therefore it is important to monitor these mutations and assess their capacity of evading previously occurred antibodies.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:It is not clear whether re-infection by SARS-CoV-2 occurs as a rare event or not, but since the start of the pandemic limited number of re-infection has been reported.
📊
Temel Bulgular & Veri:This study reports the clinical presentations and comperative genome analysis of two patients who were suspected of re-infection.
💡
Sonuç & Katkı:Therefore it is important to monitor these mutations and assess their capacity of evading previously occurred antibodies.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
It is not clear whether re-infection by SARS-CoV-2 occurs as a rare event or not, but since the start of the pandemic limited number of re-infection has been reported. This study reports the clinical presentations and comperative genome analysis of two patients who were suspected of re-infection. The patients showed mild clinical symptoms and varied antibody test results in the two episodes of infections. New generation sequencing of the isolates revealed the presence of different mutations between isolates from the previous and last infections. Therefore it is important to monitor these mutations and assess their capacity of evading previously occurred antibodies.
🔖
Bu Makaleye Atıf Yap
ÇINAR, G., AZAP, A., SARICAOĞLU, E. M., KALKAN, İ. A., GÜLTEN, E., MOHAMMED, N. S., BOZDAYI, A. M., KARAHAN, Z. C. (2022). Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 2, 100–106. https://ajindex.com/articles/539072
1 Interim Guidance on Ending Isolation and Precautions for Adults with COVID-19 [Internet]. Centers for Disease Control and Prevention. (updated March 16, 2021
cited June 25, 2021). Available from: https://www.cdc.gov/coronavirus/2019-ncov/ hcp/duration-isolation.html#references 2 Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. Mar, 2021
27(3):315- 8. [CrossRef] 3 Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response [Internet]. European Centre for Disease Prevention and Control (ECDC). (September 21, 2020
cited June 25, 2021). Available from: https://www.ecdc. europa.eu/en/publications-data/threat-assessment-brief-reinfection-sars-cov-2 4 Rehman S, Mahmood T, Aziz E, Batool R. Identification of novel mutations in SARS-COV-2 isolates from Turkey. Arch Virol. Dec, 2020
165(12):2937-44. [CrossRef] 5 Gómez-Carballa A, Bello X, Pardo-Seco J, Martinón-Torres F, Salas A. Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders. Genome Res. Oct, 2020
30(10):1434-48. [CrossRef] 6 Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. Nov 26, 2020
11(1):6013. [CrossRef] 7 Singh, B. Understanding the role of key point mutations in receptor binding domain of SARS-CoV-2 spike glycoprotein. Preprints 2020, 2020030394. [CrossRef] 8 To KK-W, Hung IF-N, Ip JP, Chu AW-H, Chan W-M, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. Aug 25, 2020
ciaa1275. [CrossRef] 9 Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARSCoV-2: a case study. Lancet Infect Dis. Jan, 2021
21(1):52- 8. [CrossRef] 10 West J, Everden S, Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Lond). Jan, 2021
21(1):e52-e53. [CrossRef] 11 Torres DA, Ribeiro LDCB, Riello APFL, Horovitz DDG, Pinto LFR, Croda J. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report. J Med Virol. Apr, 2021
93(4):1857-9. [CrossRef] 12 Nachmias V, Fusman R, Mann S, Koren G. The first case of documented Covid-19 reinfection in Israel. IDCases. 2020